Current NDC auxiliary source row outsourcing:2021-2:708

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: outsourcing_history
Product Ndc Raw: 72196-6084
Product Ndc: 72196-6084
Product Ndc Digits: 721966084
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: [empty]
Proprietary Name Suffix: [empty]
Nonproprietary Name: Glycopyrrolate
Dosage Form Name: solution
Route Name: [empty]
Marketing Category Name: OUTSOURCING FACILITY PRODUCT REPORT
Labeler Name: "Central Admixture Pharmacy Services, Inc.(080955366)"
Establishment Name: "Central Admixture Pharmacy Services, Inc.(080955366)"
Establishment Fei: [empty]
Substance Name: Glycopyrrolate
Active Ingredients Info: .2 mg/1 mL
History Active Ingredients Raw: Glycopyrrolate
History Active Ingredients Info Raw: .2 mg/1 mL
History Dosage Raw: solution
Dea Schedule: [empty]
Package Ndc Raw: 72196-6084-1
Package Ndc: 72196-6084-1
Package Ndc Digits: 7219660841
Package Ndc11: 72196608401
Package Description: 5 Ml in 1 Syringe (72196-6084-1)
Reporting Period Raw: 2021-2
Reporting Period: 2021-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/scripts/cder/outsourcingfacility/dsp_searchresult.cfm
Source Archive: outsourcing_2021-2.html
Source File: outsourcing_2021-2.html
Source Date: 2026-10-21
Source Last Modified: [null]
Source Archive Sha256: bc7efdd49e1199b17f5e7d7387ae93af0f88e347d9db02444ae35d768b768614
Source Member Sha256: bc7efdd49e1199b17f5e7d7387ae93af0f88e347d9db02444ae35d768b768614
Source Record Id: outsourcing:2021-2:708
Source Row Number: 708
Source Row Hash: 4ef661500d99d5e4570261053b99f105ee95e2400993ce4bd3dad6099541abfe
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26

Exact raw FDA source fields#

{
    "Dosage": "solution",
    "Estab. Name": "\"Central Admixture Pharmacy Services, Inc.(080955366)\"",
    "Report Year": "2021-2",
    "NDC Package Code": "72196-6084-1",
    "Active Ingredients": "Glycopyrrolate",
    "Package Description": "5 Ml in 1 Syringe (72196-6084-1)",
    "Active Ingredients Info": ".2 mg/1 mL"
}

Normalization notes#

[]

Parsed response revision#

Parsed source response revision for 2021-2

Current status projection#

Dataset: compounder
Record Source: outsourcing_history
Source Record Id: outsourcing:2021-2:708
Source Row Number: 708
Status Scope: package
Lookup Ndc: 72196-6084-1
Lookup Ndc Digits: 7219660841
Product Ndc: 72196-6084
Product Ndc Digits: 721966084
Package Ndc: 72196-6084-1
Package Ndc Digits: 7219660841
Package Ndc11: 72196608401
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2021-2
Reporting Period: 2021-2
Source Table: fda_ndc_aux_compounder
Source File: outsourcing_2021-2.html
Source Date: 2026-10-21
Source Row Hash: 4ef661500d99d5e4570261053b99f105ee95e2400993ce4bd3dad6099541abfe
Import Run Id: 20261021T042902Z
Loaded At: 2026-10-21 04:33:26